316 related articles for article (PubMed ID: 38164473)
1. Pharmacological approaches to understanding protein kinase signaling networks.
Stephenson EH; Higgins JMG
Front Pharmacol; 2023; 14():1310135. PubMed ID: 38164473
[TBL] [Abstract][Full Text] [Related]
2. Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies.
Joisa CU; Chen KA; Beville S; Stuhlmiller T; Berginski ME; Okumu D; Golitz BT; Johnson GL; Gomez SM
bioRxiv; 2023 Aug; ():. PubMed ID: 37577663
[TBL] [Abstract][Full Text] [Related]
3. Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA).
Hallal M; Braga-Lagache S; Jankovic J; Simillion C; Bruggmann R; Uldry AC; Allam R; Heller M; Bonadies N
BMC Cancer; 2021 Jul; 21(1):789. PubMed ID: 34238254
[TBL] [Abstract][Full Text] [Related]
4. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
Verkhivker GM
Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
[TBL] [Abstract][Full Text] [Related]
5. Computational methods for analysis and inference of kinase/inhibitor relationships.
Ferrè F; Palmeri A; Helmer-Citterich M
Front Genet; 2014; 5():196. PubMed ID: 25071826
[TBL] [Abstract][Full Text] [Related]
6. Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition.
East MP; Johnson GL
J Biol Chem; 2022 Feb; 298(2):101525. PubMed ID: 34958800
[TBL] [Abstract][Full Text] [Related]
7. Presence and utility of intrinsically disordered regions in kinases.
Kathiriya JJ; Pathak RR; Clayman E; Xue B; Uversky VN; Davé V
Mol Biosyst; 2014 Nov; 10(11):2876-88. PubMed ID: 25099472
[TBL] [Abstract][Full Text] [Related]
8. A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers.
Rao S; Du G; Hafner M; Subramanian K; Sorger PK; Gray NS
J Biol Chem; 2019 May; 294(21):8664-8673. PubMed ID: 30858179
[TBL] [Abstract][Full Text] [Related]
9. Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomics.
Gridling M; Ficarro SB; Breitwieser FP; Song L; Parapatics K; Colinge J; Haura EB; Marto JA; Superti-Furga G; Bennett KL; Rix U
Mol Cancer Ther; 2014 Nov; 13(11):2751-62. PubMed ID: 25189542
[TBL] [Abstract][Full Text] [Related]
10. Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques.
Lapins M; Wikberg JE
BMC Bioinformatics; 2010 Jun; 11():339. PubMed ID: 20569422
[TBL] [Abstract][Full Text] [Related]
11. Screening of cell cycle fusion proteins to identify kinase signaling networks.
Trojanowsky M; Vidovic D; Simanski S; Penas C; Schurer S; Ayad NG
Cell Cycle; 2015; 14(8):1274-81. PubMed ID: 25606665
[TBL] [Abstract][Full Text] [Related]
12. Integrating phosphoproteomics into kinase-targeted cancer therapies in precision medicine.
Wu X; Xing X; Dowlut D; Zeng Y; Liu J; Liu X
J Proteomics; 2019 Jan; 191():68-79. PubMed ID: 29621648
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a chemical affinity probe targeting Akt kinases.
Pachl F; Plattner P; Ruprecht B; Médard G; Sewald N; Kuster B
J Proteome Res; 2013 Aug; 12(8):3792-800. PubMed ID: 23795919
[TBL] [Abstract][Full Text] [Related]
14. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
15. Systems biology analysis of mitogen activated protein kinase inhibitor resistance in malignant melanoma.
Zecena H; Tveit D; Wang Z; Farhat A; Panchal P; Liu J; Singh SJ; Sanghera A; Bainiwal A; Teo SY; Meyskens FL; Liu-Smith F; Filipp FV
BMC Syst Biol; 2018 Apr; 12(1):33. PubMed ID: 29615030
[TBL] [Abstract][Full Text] [Related]
16. Computational analysis of kinase inhibitor selectivity using structural knowledge.
Lo YC; Liu T; Morrissey KM; Kakiuchi-Kiyota S; Johnson AR; Broccatelli F; Zhong Y; Joshi A; Altman RB
Bioinformatics; 2019 Jan; 35(2):235-242. PubMed ID: 29985971
[TBL] [Abstract][Full Text] [Related]
17. Prediction of kinase inhibitor response using activity profiling, in vitro screening, and elastic net regression.
Tran TP; Ong E; Hodges AP; Paternostro G; Piermarocchi C
BMC Syst Biol; 2014 Jun; 8():74. PubMed ID: 24961498
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer.
Johnson GL; Stuhlmiller TJ; Angus SP; Zawistowski JS; Graves LM
Clin Cancer Res; 2014 May; 20(10):2516-22. PubMed ID: 24664307
[TBL] [Abstract][Full Text] [Related]
19. Using small molecules and chemical genetics to interrogate signaling networks.
Carlson SM; White FM
ACS Chem Biol; 2011 Jan; 6(1):75-85. PubMed ID: 21077690
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
